Vedantra Pharmaceuticals, Inc.

Cambridge, Massachusetts, United States
Purpose
to develop an efficacious vaccine against malaria using novel nanoparticle-based technologies termed Interbilayer-Crosslinked Multilamellar Vesicles (ICMVs) and malarial antigens
Grantee
Division
Global Health
Date
OCTOBER 2012
Region served
GLOBAL
Committed amount
$1,350,938
Grant topic
Discovery and Translational Sciences
Duration (months)
53
Grantee location
Cambridge, Massachusetts, United States
Related work

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.